Charles Ruprecht
Principal
Charlie is a Principal at GHO Capital, bringing a comprehensive background in private equity and corporate finance within the healthcare sector. His investment efforts are focused on the biopharma services and healthcare IT subsectors, with a particular emphasis on technology-enabled platforms where these two disciplines converge to drive efficiency and innovation across the life sciences ecosystem.
Charlie is actively involved in driving strategic growth and working alongside management to realize the full potential of companies across the GHO portfolio, working closely with the management teams of Sapio Sciences, a leading provider of cloud-based scientific data management and informatics solutions, and Velocity Clinical Research, a leading global site network for clinical trials.
Having joined GHO in 2022, Charlie currently serves on the board of Sapio Sciences and works closely with the management team at Velocity Clinical Research. Charlie previously served as a Vice President at Webster Equity Partners, where he was responsible for originating, evaluating, and executing new investments across healthcare services and outsourced pharmaceutical services.
He began his career in Investment Banking at Bank of America Merrill Lynch. Charlie holds a Bachelor of Science from Boston University.
